AbbVie Nears $11 Billion Deal to Acquire Biotech Apogee Therapeutics
AbbVie is closing in on an acquisition of Apogee Therapeutics valued at nearly $11 billion, a move that would rank among the drug giant's largest purchases in recent years. The deal arrives as Big Pharma companies accelerate efforts to repl
NDNewsDialy Desk2 MIN READ
SOURCE
Keep reading
More from the desk.
Tomorrow · 06:00
Start tomorrow already ahead.
Five stories, a two-minute read, zero noise — the world before your first coffee.